Skip to main content
Clinical Trials/NCT00473993
NCT00473993CompletedNot Applicable

Hepatitis C Bei Opioidabhängigen in Der Praxis, Eine Querschnittsuntersuchung

Seidenberg, Arztpraxis A., M.D.0 sitesStarted: July 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor

Study Overview

Brief Summary

Hepatitis C viral infection is common among opioid addicts in Zurich, Switzerland. The majority undergoes a maintenance treatment with methadone, heroin or buprenorphine. While stabilized by an opioid maintenance treatment (OMT)chronic hepatitis C can be treated with pegylated interferon plus ribavirin. As not sufficiently known, the results are comparable to the results of the treatment of nonaddicts.

Our crossectional study investigates how many patients undergoing OMT are adequately investigated concerning hepatitis C. If not, why are they not adequately investigated and treated? Representative data are collected in the local clinics and medical practices involved in OMT in the Kanton of Zurich. The patients files are revised and the involved doctors are asked through a structured interview.

Detailed Description

Study Design

Study Type
Observational
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Medical practices and clinics involved in opioid maintenance treatment in the Kanton of Zurich, Switzerland

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Seidenberg, Arztpraxis A., M.D.
Sponsor Class
Indiv

Similar Trials